Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients.

Hallin J, Engstrom LD, Hargis L, Calinisan A, Aranda R, Briere DM, Sudhakar N, Bowcut V, Baer BR, Ballard JA, Burkard MR, Fell JB, Fischer JP, Vigers GP, Xue JY, Gatto S, Fernandez-Banet J, Pavlicek A, Velastegui K, Chao RC, Barton J, Pierobon M, Baldelli E, Patricoin EF, Cassidy DP, Marx MA, Rybkin II, Johnson ML, Ou SI, Lito P, Papadopoulos KP, Janne PA, Olson P, Christensen JG.

Cancer Discov. 2019 Oct 28. pii: CD-19-1167. doi: 10.1158/2159-8290.CD-19-1167. [Epub ahead of print]

PMID:
31658955
2.

Effect of Match Location, Team Ranking, Match Status and Tactical Dimensions on the Offensive Performance in Spanish 'La Liga' Soccer Matches.

González-Rodenas J, Aranda-Malavés R, Tudela-Desantes A, Calabuig Moreno F, Casal CA, Aranda R.

Front Psychol. 2019 Sep 12;10:2089. doi: 10.3389/fpsyg.2019.02089. eCollection 2019.

3.

The effect of arm-crank exercise training on power output, spirometric and cardiac function and level of autonomy in persons with tetraplegia.

Brizuela G, Sinz S, Aranda R, Martínez-Navarro I.

Eur J Sport Sci. 2019 Oct 11:1-9. doi: 10.1080/17461391.2019.1674927. [Epub ahead of print]

PMID:
31566476
4.

"REOFUT" as an Observation Tool for Tactical Analysis on Offensive Performance in Soccer: Mixed Method Perspective.

Aranda R, González-Ródenas J, López-Bondia I, Aranda-Malavés R, Tudela-Desantes A, Anguera MT.

Front Psychol. 2019 Jun 28;10:1476. doi: 10.3389/fpsyg.2019.01476. eCollection 2019.

5.

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.

Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group.

Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2.

6.

Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.

Guzman M, Gomez R, Romero SP, Aranda R, Andrey JL, Pedrosa MJ, Egido J, Gomez F.

Int J Clin Pract. 2018 Nov;72(11):e13217. doi: 10.1111/ijcp.13217. Epub 2018 Sep 24.

PMID:
30248211
7.

New distribution record of Epipompilus aztecus (Cresson, 1869) (Hymenoptera: Pompilidae) in the Brazilian Pantanal.

Aranda R.

Braz J Biol. 2019 Jul-Sep;79(3):466-469. doi: 10.1590/1519-6984.183386. Epub 2018 Sep 13.

8.
9.

Fatal falls in the elderly and the presence of proximal femur fractures.

Schick S, Heinrich D, Graw M, Aranda R, Ferrari U, Peldschus S.

Int J Legal Med. 2018 Nov;132(6):1699-1712. doi: 10.1007/s00414-018-1876-7. Epub 2018 Jun 7.

PMID:
29882059
10.

The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.

Briere D, Sudhakar N, Woods DM, Hallin J, Engstrom LD, Aranda R, Chiang H, Sodré AL, Olson P, Weber JS, Christensen JG.

Cancer Immunol Immunother. 2018 Mar;67(3):381-392. doi: 10.1007/s00262-017-2091-y. Epub 2017 Nov 9.

PMID:
29124315
11.

Wearable wireless User Interface Cursor-Controller (UIC-C).

Marjanovic N, Kerr K, Aranda R, Hickey R, Esmailbeigi H.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3852-3855. doi: 10.1109/EMBC.2017.8037697.

PMID:
29060738
12.

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models.

Engstrom LD, Aranda R, Lee M, Tovar EA, Essenburg CJ, Madaj Z, Chiang H, Briere D, Hallin J, Lopez-Casas PP, Baños N, Menendez C, Hidalgo M, Tassell V, Chao R, Chudova DI, Lanman RB, Olson P, Bazhenova L, Patel SP, Graveel C, Nishino M, Shapiro GI, Peled N, Awad MM, Jänne PA, Christensen JG.

Clin Cancer Res. 2017 Nov 1;23(21):6661-6672. doi: 10.1158/1078-0432.CCR-17-1192. Epub 2017 Aug 1.

13.

Anti-fungal and Anti-Mycobacterial activity of plants of Nuevo Leon, Mexico.

Garza BAA, Arroyo JL, González GG, González EG, González EG, de Torres NW, Aranda RS.

Pak J Pharm Sci. 2017 Jan;30(1):17-21.

PMID:
28603107
14.

In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4.

González LT, Minsky NW, Espinosa LE, Aranda RS, Meseguer JP, Pérez PC.

BMC Complement Altern Med. 2017 Jan 13;17(1):39. doi: 10.1186/s12906-016-1506-1.

15.

DNA purification using dynamic solid-phase extraction on a rotationally-driven polyethylene-terephthalate microdevice.

Jackson KR, Borba JC, Meija M, Mills DL, Haverstick DM, Olson KE, Aranda R, Garner GT, Carrilho E, Landers JP.

Anal Chim Acta. 2016 Sep 21;937:1-10. doi: 10.1016/j.aca.2016.06.036. Epub 2016 Jul 6.

PMID:
27590539
16.

Environmental Heterogeneity in Parasitoid-Host Interaction for Mutillidae (Hymenoptera: Apocrita).

Aranda R, Graciolli G.

Environ Entomol. 2016 Oct;45(5):1146-1153. Epub 2016 Aug 23.

PMID:
27555643
17.

Living in the Shadows: Plight of the Undocumented.

Aranda R.

J Clin Psychol. 2016 Aug;72(8):795-806. doi: 10.1002/jclp.22361. Epub 2016 Aug 23. Review.

18.

Objective Method for Presumptive Field-Testing of Illicit Drug Possession Using Centrifugal Microdevices and Smartphone Analysis.

Krauss ST, Remcho TP, Lipes SM, Aranda R 4th, Maynard HP 3rd, Shukla N, Li J, Tontarski RE Jr, Landers JP.

Anal Chem. 2016 Sep 6;88(17):8689-97. doi: 10.1021/acs.analchem.6b01982. Epub 2016 Aug 15.

PMID:
27525468
19.

Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.

Ruiz G, Andrey JL, Puerto JL, Escobar MA, Romero SP, Aranda R, Pedrosa MJ, Gomez F.

Int J Cardiol. 2016 Nov 1;222:594-602. doi: 10.1016/j.ijcard.2016.07.292. Epub 2016 Aug 3.

PMID:
27513657
20.

Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis.

Dellon ES, Higgins LL, Beitia R, Rusin S, Woosley JT, Veerappan R, Selitsky SR, Parker JS, Genta RM, Lash RH, Aranda R, Peach RJ, Grimm M.

Aliment Pharmacol Ther. 2016 Jul;44(2):189-97. doi: 10.1111/apt.13672. Epub 2016 May 18.

21.

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.

Sandborn WJ, Feagan BG, Wolf DC, D'Haens G, Vermeire S, Hanauer SB, Ghosh S, Smith H, Cravets M, Frohna PA, Aranda R, Gujrathi S, Olson A; TOUCHSTONE Study Group.

N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248.

22.

Effect of the Game Design, the Goal Type and the Number of Players on Intensity of Play in Small-Sided Soccer Games in Youth Elite Players.

González-Rodenas J, Calabuig F, Aranda R.

J Hum Kinet. 2015 Dec 30;49:229-35. doi: 10.1515/hukin-2015-0125. eCollection 2015 Dec 22.

23.

Review and future prospects for DNA barcoding methods in forensic palynology.

Bell KL, Burgess KS, Okamoto KC, Aranda R, Brosi BJ.

Forensic Sci Int Genet. 2016 Mar;21:110-6. doi: 10.1016/j.fsigen.2015.12.010. Epub 2015 Dec 21. Review.

PMID:
26751251
24.

Sparse Reconstruction Challenge for diffusion MRI: Validation on a physical phantom to determine which acquisition scheme and analysis method to use?

Ning L, Laun F, Gur Y, DiBella EV, Deslauriers-Gauthier S, Megherbi T, Ghosh A, Zucchelli M, Menegaz G, Fick R, St-Jean S, Paquette M, Aranda R, Descoteaux M, Deriche R, O'Donnell L, Rathi Y.

Med Image Anal. 2015 Dec;26(1):316-31. doi: 10.1016/j.media.2015.10.012. Epub 2015 Nov 10.

25.

Essential oils from Zanthoxylum fagara Wild Lime, Ruta chalepensis L. and Thymus vulgaris L.: Composition and activity against Aedes aegypti larvae.

Pérez López LA, de la Torre YC, Cirio AT, de Torres NW, Flores Suárez AE, Aranda RS.

Pak J Pharm Sci. 2015 Sep;28(5 Suppl):1911-5.

PMID:
26525020
26.

Sparse and Adaptive Diffusion Dictionary (SADD) for recovering intra-voxel white matter structure.

Aranda R, Ramirez-Manzanares A, Rivera M.

Med Image Anal. 2015 Dec;26(1):243-55. doi: 10.1016/j.media.2015.10.002. Epub 2015 Oct 22.

PMID:
26519793
27.

Quantifying the degradation of TNT and RDX in a saline environment with and without UV-exposure.

Sisco E, Najarro M, Bridge C, Aranda R 4th.

Forensic Sci Int. 2015 Jun;251:124-31. doi: 10.1016/j.forsciint.2015.04.002. Epub 2015 Apr 14.

PMID:
25909992
28.

Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus.

Garcia-Egido A, Andrey JL, Puerto JL, Aranda RM, Pedrosa MJ, López-Sáez JB, Rosety M, Gomez F.

Int J Clin Pract. 2015 May;69(5):550-9. doi: 10.1111/ijcp.12567. Epub 2015 Feb 24.

PMID:
25707623
29.

Fluctuations of the anthropometric indices and mortality of patients with incident heart failure: a prospective study in the community.

Aranda RM, Puerto JL, Andrey JL, Escobar MA, García-Egido A, Romero SP, Pedrosa MJ, Gómez F.

Int J Clin Pract. 2015 Feb;69(2):169-79. doi: 10.1111/ijcp.12479. Epub 2014 Jul 16.

PMID:
25040352
30.

Discovery of syn-/anti-cocaine-N-oxide diastereomers in unwashed postmortem hair via LC-MS-MS.

Marsh CM, Crawley LR, Himes SK, Aranda R 4th, Miller ML.

J Anal Toxicol. 2014 Jul-Aug;38(6):360-7. doi: 10.1093/jat/bku041. Epub 2014 Apr 28.

PMID:
24782141
31.

A flocking based method for brain tractography.

Aranda R, Rivera M, Ramirez-Manzanares A.

Med Image Anal. 2014 Apr;18(3):515-30. doi: 10.1016/j.media.2014.01.009. Epub 2014 Feb 10.

PMID:
24583805
32.

Myers-Briggs personality preferences may enhance physician leadership success in non-clinical jobs.

Aranda R, Tilton S.

Physician Exec. 2013 May-Jun;39(3):14-6, 18, 20. No abstract available.

PMID:
23802383
33.

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.

Mayer L, Sandborn WJ, Stepanov Y, Geboes K, Hardi R, Yellin M, Tao X, Xu LA, Salter-Cid L, Gujrathi S, Aranda R, Luo AY.

Gut. 2014 Mar;63(3):442-50. doi: 10.1136/gutjnl-2012-303424. Epub 2013 Mar 5.

34.

Blood rheology effect of submaximal exercise on young subjects.

Romagnoli M, Alis R, Martinez-Bello V, Sanchis-Gomar F, Aranda R, Gómez-Cabrera MC.

Clin Hemorheol Microcirc. 2014;56(2):111-7. doi: 10.3233/CH-121657.

PMID:
23302596
35.

[Self-medication behavior among pregnant women user of the Instituto Nacional Materno Perinatal, Peru 2011].

Miní E, Varas R, Vicuña Y, Lévano M, Rojas L, Medina J, Butron J, Aranda R, Gutierrez EL.

Rev Peru Med Exp Salud Publica. 2012 Jun;29(2):212-7. Spanish.

36.

Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy.

Genovese MC, Schiff M, Luggen M, Le Bars M, Aranda R, Elegbe A, Dougados M.

J Rheumatol. 2012 Aug;39(8):1546-54. doi: 10.3899/jrheum.111531. Epub 2012 Jul 15.

PMID:
22798265
37.

Abatacept for Crohn's disease and ulcerative colitis.

Sandborn WJ, Colombel JF, Sands BE, Rutgeerts P, Targan SR, Panaccione R, Bressler B, Geboes K, Schreiber S, Aranda R, Gujrathi S, Luo A, Peng Y, Salter-Cid L, Hanauer SB.

Gastroenterology. 2012 Jul;143(1):62-69.e4. doi: 10.1053/j.gastro.2012.04.010. Epub 2012 Apr 12.

PMID:
22504093
38.

Forensic utility of carbon isotope ratio variations in PVC tape backings.

Dietz ME, Stern LA, Mehltretter AH, Parish A, McLasky V, Aranda R 4th.

Sci Justice. 2012 Mar;52(1):25-32. doi: 10.1016/j.scijus.2011.05.003. Epub 2011 Jul 5.

PMID:
22325908
39.

Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study.

Keystone EC, Kremer JM, Russell A, Box J, Abud-Mendoza C, Elizondo MG, Luo A, Aranda R, Delaet I, Swanink R, Gujrathi S, Luggen M.

Ann Rheum Dis. 2012 Jun;71(6):857-61. doi: 10.1136/annrheumdis-2011-200355. Epub 2012 Feb 2.

PMID:
22302417
40.

Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity.

Vaughan AE, Mendoza R, Aranda R, Battini JL, Miller AD.

J Virol. 2012 Feb;86(3):1661-9. doi: 10.1128/JVI.06073-11. Epub 2011 Nov 16.

41.

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study.

Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S, Saldate C, Aranda R, Becker JC, Nys M, le Bars M, Reed DM, Poncet C, Dougados M.

Ann Rheum Dis. 2011 Nov;70(11):2003-7. doi: 10.1136/annrheumdis-2011-200316. Epub 2011 Sep 12.

42.

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.

Kremer JM, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Westhovens R, Li T, Zhou X, Becker JC, Aranda R, Peterfy C, Genant HK.

Ann Rheum Dis. 2011 Oct;70(10):1826-30. doi: 10.1136/ard.2010.139345.

43.

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

Genovese MC, Covarrubias A, Leon G, Mysler E, Keiserman M, Valente R, Nash P, Simon-Campos JA, Porawska W, Box J, Legerton C 3rd, Nasonov E, Durez P, Aranda R, Pappu R, Delaet I, Teng J, Alten R.

Arthritis Rheum. 2011 Oct;63(10):2854-64. doi: 10.1002/art.30463.

44.

A model for harmonizing flow cytometry in clinical trials.

Maecker HT, McCoy JP Jr; FOCIS Human Immunophenotyping Consortium, Amos M, Elliott J, Gaigalas A, Wang L, Aranda R, Banchereau J, Boshoff C, Braun J, Korin Y, Reed E, Cho J, Hafler D, Davis M, Fathman CG, Robinson W, Denny T, Weinhold K, Desai B, Diamond B, Gregersen P, Di Meglio P, Nestle FO, Peakman M, Villanova F, Ferbas J, Field E, Kantor A, Kawabata T, Komocsar W, Lotze M, Nepom J, Ochs H, O'Lone R, Phippard D, Plevy S, Rich S, Roederer M, Rotrosen D, Yeh JH.

Nat Immunol. 2010 Nov;11(11):975-8. doi: 10.1038/ni1110-975. Erratum in: Nat Immunol. 2010 Nov;11(11):979. DiMeglio, Paola [corrected to Di Meglio, Paola]; Nestle, Frank [corrected to Nestle, Frank O]; Villnova, Federica [corrected to Villanova, Federica]. Nat Immunol. 2011 Mar;12(3):271.

45.

Forensic utility of isotope ratio analysis of the explosive urea nitrate and its precursors.

Aranda R 4th, Stern LA, Dietz ME, McCormick MC, Barrow JA, Mothershead RF 2nd.

Forensic Sci Int. 2011 Mar 20;206(1-3):143-9. doi: 10.1016/j.forsciint.2010.07.030. Epub 2010 Aug 21.

PMID:
20729019
46.

An evaluation of commercial DNA extraction kits for the isolation of bacterial spore DNA from soil.

Dineen SM, Aranda R 4th, Anders DL, Robertson JM.

J Appl Microbiol. 2010 Dec;109(6):1886-96. doi: 10.1111/j.1365-2672.2010.04816.x.

47.

Targeting lymphocyte co-stimulation: from bench to bedside.

Felix NJ, Suri A, Salter-Cid L, Nadler SG, Gujrathi S, Corbo M, Aranda R.

Autoimmunity. 2010 Nov;43(7):514-25. doi: 10.3109/08916931003674741. Review.

PMID:
20429850
48.

Evaluation of commercial RNA extraction kits for the isolation of viral MS2 RNA from soil.

Dineen SM, Aranda R 4th, Dietz ME, Anders DL, Robertson JM.

J Virol Methods. 2010 Sep;168(1-2):44-50. doi: 10.1016/j.jviromet.2010.04.014. Epub 2010 Apr 24.

PMID:
20417664
49.

Comparison and evaluation of RNA quantification methods using viral, prokaryotic, and eukaryotic RNA over a 10(4) concentration range.

Aranda R 4th, Dineen SM, Craig RL, Guerrieri RA, Robertson JM.

Anal Biochem. 2009 Apr 1;387(1):122-7. doi: 10.1016/j.ab.2009.01.003. Epub 2009 Jan 15.

PMID:
19454255
50.

Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study.

Westhovens R, Kremer JM, Moreland LW, Emery P, Russell AS, Li T, Aranda R, Becker JC, Qi K, Dougados M.

J Rheumatol. 2009 Apr;36(4):736-42. doi: 10.3899/jrheum.080813. Epub 2009 Feb 27.

PMID:
19273451

Supplemental Content

Loading ...
Support Center